Home › NCT01629017

Long Term Effects On Recipients of Hematopoietic Stem Cell Transplantation

Longitudinal Evaluation of Recipients of Hematopoietic Stem Cell Transplantation (HSCT)

Who can join

Up to age 18 · All sexes

Inclusion Criteria:

* Participant is scheduled to receive OR has received a hematopoietic stem cell transplant (HSCT) for any condition.
* Participant may have had a HSCT in another institution than Lucile Packard Children's Hospital (LPCH) yet has transferred follow-up long-term care to our institution and is being seen through the late-effects clinic from the Pediatric HSCT program.
* Participant AND/OR parent/legally authorized representative is able to provide written informed consent and assent (as applicable) for participation.

Exclusion Criteria:

* Participant has relapsed from a malignant diagnosis post HSCT and is not being worked-up for a new HSCT.
* Participant or patient's authorized guardian is unable to provide consent and assent

About the study

This project allows for the systematic collection and analysis of long-term follow-up clinical parameters in children who have received a stem cell transplant. The data collected will assist in determining appropriate intervention and treatment plans for patients enrolled on this study. In addition, future patients may benefit by having the ability to anticipate problems and develop methods of prevention or early intervention.

Sponsor: Stanford University · Participants: 800 · Started: 1995-01

Contact the study team

Official record on ClinicalTrials.gov — NCT01629017

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.